• Back to NHRI
【NHRI】Technology Transfer and Incubation Center
 
Skip to content
  • Home
  • Latest News
  • The IP Spotlight
    • 2019US-Bio
    • NHRI-Spotlight
      • Small Molecule Drugs
      • Protein Drugs
      • Vaccine Development
      • Biomedical Engineering
      • Diagnostic Technology
      • Platform Technology
  • About TTIC
    • Introduction
    • Organization
    • Our Services
    • Contact
    • Location
  • Intellectual Property Management & Technology Transfer
    • Mission
    • Investment announcement
    • Issued Patents
    • Technology Transfer Result
  • Industry- Academia Collaboration Planning
    • Mission
    • Exhibition activities
      • Bio Taiwan
      • Taiwan innotech Expo
      • US BIO Annual International Convention
  • Innovation & Incubation
    • Mission
    • Environment
    • Regulation
    • Resident Company
  • Download
  • Related Sites
  • 銀髮產業聚落
  • en
    • tw
Home Latest News

Latest News

  • Technology Available for Industry-Academia Collaboration or Technology Licensing. “Opioid Receptor Allosteric Modifier: DBPR116” (2021/1/28)
  • NHRI technology, “Induction of Stem Cell-derived Exosomes for Disease Treatment” available for technology licensing (exclusive license), 2020/08/17
  • Technology Available for Technology Licensing. “Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine(Jul 20,2020)
  • Building a Biomedical Value Chain and Accelerating the Development of the Biomedical Industry
  • Technology Available for Industry-Academia Collaboration or Technology Licensing. “A Potential COVID-19 Therapeutic Compound”(2020/4/16)

More


Patents

  • 2021(until 2021/02/08)
Issue date Patent Title Patent No.
2020/1/1 BENZIMIDAZOLE COMPOUNDS AND USE THEREOF FOR TREATING ALZHEIMER’S DISEASE OR HUNTINGTON’S DISEASE TWI715156
More: 2020 Issued patents

More

Comments are closed.

  • 活動錦集

     
     
     
     
     
     
     
     
     
  • 創新育成

    • 【歡迎踴躍報名】林口新創園生醫小聚
    • 【活動轉知】2020 Meet Taipei 亞洲最大創新創業嘉年華 敬邀參觀
    • |創業 Talk Show|創業,不是單打獨鬥,而是團隊合作|碁米庫斯生物科技股份有限公司 黃少穎董事長
  • 技術移轉

    • 本院「調控油脂吸收之中孔洞奈米矽球」公開徵求技術移轉廠商(2021/2/8)
    • Technology Available for Industry-Academia Collaboration or Technology Licensing. “Opioid Receptor Allosteric Modifier: DBPR116” (2021/1/28)
  • 產學合作

    • 本院「應用於細胞治療之新穎癌症抗原(cancer antigen)抗體」公開徵求產學合作廠商(2021/2/25)
    • 徵求「台灣罕病及難症之診斷治療與藥物開發」產學合作廠商(2021/1/18)
National Health Research Institutes
Technology Transfer and Incubation Center
Tel:+886-37-206166 #33201
Fax:+886-37-583287
Adress:350 苗栗縣竹南鎮科研路35號
No.35, Keyan Rd., Zhunan Township, Miaoli County 350

Copyright by National Health Research Institutes
Powered by Nirvana & WordPress.